Trending
December 18, 2024

Cara Therapeutics and Tvardi Therapeutics To Merge

December 18, 2024

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

December 18, 2024

Tessera Therapeutics Receives Investment from The Bill and Melinda Gates Foundation

December 17, 2024

Alphina Therapeutics Appoints Marc Damelin, Ph.D. as Chief Scientific Officer

December 17, 2024

Akamis Bio Closes $60 Million Series A Funding

December 17, 2024

Alira Health Secures $100M Growth Debt Facility from Symbiotic Capital

December 17, 2024

Upstream Bio Appoints Allison Ambrose as General Counsel

December 16, 2024

Trevi Therapeutics Prices of $50 Million Underwritten Offering

December 16, 2024

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

December 16, 2024

Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer

December 16, 2024

Promise Bio Emerges From Stealth With $8.3M Seed Investment

December 16, 2024

VectorY Appoints Jim Scibetta as CEO

December 16, 2024

KalVista Appoints Jeb Ledell as Chief Operating Officer

December 13, 2024

Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors

December 12, 2024

Candel Therapeutics Prices of Public Offering

December 12, 2024

Proven Behavior Solutions Acquires Prism Autism Education & Consultation